Correlation Between Endonovo Therapeutics and NetEase Inc

Can any of the company-specific risk be diversified away by investing in both Endonovo Therapeutics and NetEase Inc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Endonovo Therapeutics and NetEase Inc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Endonovo Therapeutics and NetEase, you can compare the effects of market volatilities on Endonovo Therapeutics and NetEase Inc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Endonovo Therapeutics with a short position of NetEase Inc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Endonovo Therapeutics and NetEase Inc.

Diversification Opportunities for Endonovo Therapeutics and NetEase Inc

-0.29

Correlation Coefficient

Endonovo Therapeutics  NetEase Inc

Very good diversification

The 3 months correlation between Endonovo and NetEase Inc is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Endonovo Therapeutics and NetEase in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetEase Inc and Endonovo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Endonovo Therapeutics are associated (or correlated) with NetEase Inc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetEase Inc has no effect on the direction of Endonovo Therapeutics i.e., Endonovo Therapeutics and NetEase Inc go up and down completely randomly.

Pair Corralation between Endonovo Therapeutics and NetEase Inc

Given the investment horizon of 90 days Endonovo Therapeutics is expected to generate 5.06 times more return on investment than NetEase Inc. However, Endonovo Therapeutics is 5.06 times more volatile than NetEase. It trades about 0.13 of its potential returns per unit of risk. NetEase is currently generating about 0.06 per unit of risk. If you would invest  0.05  in Endonovo Therapeutics on December 22, 2024 and sell it today you would lose (0.03) from holding Endonovo Therapeutics or give up 60.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

Endonovo Therapeutics  vs.  NetEase

Endonovo Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Endonovo Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental indicators, Endonovo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

NetEase Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NetEase are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, NetEase Inc reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Endonovo Therapeutics and NetEase Inc

The main advantage of trading using opposite Endonovo Therapeutics and NetEase Inc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Endonovo Therapeutics position performs unexpectedly, NetEase Inc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetEase Inc will offset losses from the drop in NetEase Inc's long position.

The idea behind Endonovo Therapeutics and NetEase pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.